These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10688271)

  • 1. Advances in understanding drug metabolism and its contribution to variability in patient response.
    Tucker GT
    Ther Drug Monit; 2000 Feb; 22(1):110-3. PubMed ID: 10688271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics.
    Brosen K
    Clin Pharmacokinet; 1990 Mar; 18(3):220-39. PubMed ID: 2182263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping for drug-metabolizing enzymes--does the promise meet the reality?
    Gardiner SJ; Begg EJ
    Pharmacogenomics; 2004 Dec; 5(8):1033-6. PubMed ID: 15584874
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction phenotyping to assess victim drug-drug interaction risks.
    Di L
    Expert Opin Drug Discov; 2017 Nov; 12(11):1105-1115. PubMed ID: 28820269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.
    Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J
    Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpatient variability: genetic predisposition and other genetic factors.
    West WL; Knight EM; Pradhan S; Hinds TS
    J Clin Pharmacol; 1997 Jul; 37(7):635-48. PubMed ID: 9243358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of probe drugs as predictors of drug metabolism in humans.
    Kivistö KT; Kroemer HK
    J Clin Pharmacol; 1997 Jan; 37(S1):40S-48S. PubMed ID: 9048284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism.
    Isvoran A; Louet M; Vladoiu DL; Craciun D; Loriot MA; Villoutreix BO; Miteva MA
    Drug Discov Today; 2017 Feb; 22(2):366-376. PubMed ID: 27693711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From the Viewpoint of Drug Metabolism Research].
    Nakajima M
    Yakugaku Zasshi; 2017; 137(6):697-705. PubMed ID: 28566576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
    Mathijssen RH; van Schaik RH
    Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.